Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial.

meplazumab - Jiangsu Pacific Meinuoke Biopharmaceutical, Air Force Medical University

http://www.ncbi.nlm.nih.gov/pubmed/34001849

May 20, 2021